Minneapolis, MN, January 18, 2012 – Bayer HealthCare announced today that it has opened a new, expanded facility for the Interventional franchise within its Medical Care’s Radiology and Interventional business. Located at its Coon Rapids headquarters site, the new facility features new research and development labs as well as manufacturing clean rooms. The Interventional franchise discovers, markets and manufactures therapeutic medical devices.
“This expansion nearly doubles our infrastructure in Minnesota, home of our Interventional franchise, and provides room for future growth in our cardiovascular and peripheral vascular disease device lines,” said Alan Main, president of Bayer HealthCare's Medical Care business, which includes the Radiology & Interventional and Diabetes Care businesses of Bayer HealthCare.
“This is great news for Minnesota,” said Mark Phillips, Commissioner, Minnesota Department of Employment and Economic Development. “Bayer’s infrastructure investment reaffirms the state’s position as a leader for medical devices.”
The building comprises roughly 80,000 square feet of space. Scientists and research technicians are now working in new laboratory space and the company plans to use new clean rooms to expand production of Cotavance, a drug-eluting balloon for the treatment of peripheral artery disease presently approved for use in the European Union, as the company introduces it into additional markets.
“This facility embodies the spirit of Bayer’s mission – ‘Science for a Better Life’ – through design that encourages employees to collaborate on new product ideas and work efficiently to manufacture interventional devices that provide physicians with less invasive solutions – alternatives to surgery – for a growing number of medical conditions,” said Jack Darby, Head of Bayer’s Interventional franchise. “We want to thank the firms that worked with us on the project and particularly recognize the support of the City of Coon Rapids.”
The global headquarters of the Interventional franchise is located in Coon Rapids, MN and employs approximately 225 individuals locally. Doing business now as part of Bayer Medical Care’s Radiology and Interventional business, the Interventional franchise formerly operated under Bayer’s MEDRAD brand. The Interventional franchise develops, markets and services interventional medical devices used to treat disease. Its product offerings include fluid injection systems for cardiology and endovascular devices for the treatment of cardiovascular and peripheral artery diseases. Visit www.ri.bayer.com for more information on the Radiology & Interventional business.
The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 16.9 billion (2010), is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare’s aim is to discover and manufacture products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 55,700 employees (Dec 31, 2010) and is represented in more than 100 countries. Find more information at www.bayerhealthcare.com.
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.